ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Lary A. Robinson
William H. Fleming
Timothy A. Galbraith
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, L. A.
Right arrow Articles by Galbraith, T. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, L. A.
Right arrow Articles by Galbraith, T. A.

Ann Thorac Surg 1993;55:1115-1122
© 1993 The Society of Thoracic Surgeons

Articles

Intrapleural doxycycline control of malignant pleural effusions

Lary A. Robinson, MD*, William H. Fleming, MD, Timothy A. Galbraith, MD

Section of Thoracic and Cardiovascular Surgery, University of Nebraska Medical Center, Omaha, Nebraska USA

* Address reprint requests to Dr Robinson, Section of Thoracic and Cardiovascular Surgery, University of Nebraska Medical Center, 600 South 42nd St, Omaha, NE 68198-2315.

The intrapleural instillation of agents for pleural sclerosis has proved effective in preventing the reaccumulation of symptomatic malignant pleural effusions. Because manufacture of the most popular agent, tetracycline, was recently discontinued, a preliminary study was undertaken to evaluate an alternative agent, doxycycline, for treating symptomatic malignant pleural effusions. From November 1991 to September 1992, 21 patients with symptomatic malignant pleural effusions have undergone overnight chest tube drainage followed by intrapleural instillation of 10 mL 1% lidocaine and then doxycycline, 500 mg in 30 mL 0.9% saline solution. The chest tube was clamped 2 hours with patient repositioning every 15 minutes. Tubes were removed when drainage was less than 50 mL/8 h. Of surviving patients, a complete objective response at 1 month was obtained in 88% ([equation]), who were free of a symptomatic or radiographic recurrence of the effusion. Complications included mild pain in 23% ([equation]), moderate pain requiring analgesics in 19% ([equation]), and mild fever in 5% ([equation]). There were no treatment-related deaths. The mean time for chest tube removal was 1.7 ± 0.7 days after the last treatment. Based on this preliminary study, we conclude that doxycycline is a highly effective agent for the palliative treatment of symptomatic malignant pleural effusions. Its safety profile and efficacy compare favorably with those of tetracycline and other agents used for pleural sclerosis.




This article has been cited by other articles:


Home page
 ThoraxHome page
M. E. Roberts, E. Neville, R. G. Berrisford, G. Antunes, N. J. Ali, and on behalf of the BTS Pleural Disease Guideline Gro
Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010
Thorax, August 1, 2010; 65(Suppl_2): ii32 - ii40.
[Full Text] [PDF]

Home page
 Oxford Textbook of Palliative MedicineHome page
K.-S. Chan, D. M. W. Tse, M. M. K. Sham, and A. B. Thorsen
11.1 Palliative medicine in malignant respiratory diseases
Oxford Textbook of Palliative Medicine, January 1, 2010; 4(1): med-9780198570295-chapter - med-9780198570295-chapter.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
W. H. Warren, R. Kalimi, L. M. Khodadadian, and A. W. Kim
Management of Malignant Pleural Effusions Using the Pleurx Catheter
Ann. Thorac. Surg., March 1, 2008; 85(3): 1049 - 1055.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Cardiothorac SurgHome page
W. H. Warren, A. W. Kim, and M. J. Liptay
Identification of clinical factors predicting Pleurx(R) catheter removal in patients treated for malignant pleural effusion
Eur J Cardiothorac Surg, January 1, 2008; 33(1): 89 - 94.
[Abstract] [Full Text] [PDF]

Home page
 Am J Sports MedHome page
S. G. Tejwani, S. B. Cohen, and J. P. Bradley
Management of Morel-Lavallee Lesion of the Knee: Twenty-Seven Cases in the National Football League
Am. J. Sports Med., July 1, 2007; 35(7): 1162 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
G Antunes, E Neville, J Duffy, and N Ali
BTS guidelines for the management of malignant pleural effusions
Thorax, May 1, 2003; 58(90002): ii29 - 38.
[Full Text]

Home page
 Ann. Thorac. Surg.Home page
J. B. Putnam Jr, G. L. Walsh, S. G. Swisher, J. A. Roth, D. M. Suell, A. A. Vaporciyan, W. R. Smythe, K. W. Merriman, and L. L. DeFord
Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter
Ann. Thorac. Surg., February 1, 2000; 69(2): 369 - 375.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
E. M. Marom, E. F. Patz Jr, J. J. Erasmus, H. P. McAdams, P. C. Goodman, and J. E. Herndon
Malignant Pleural Effusions: Treatment with Small-Bore-Catheter Thoracostomy and Talc Pleurodesis
Radiology, January 1, 1999; 210(1): 277 - 281.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
A. Yellin
Doxycycline for malignant effusions
Ann. Thorac. Surg., April 1, 1994; 57(4): 1053 - 1053.
[PDF]

Home page
 Ann. Thorac. Surg.Home page
L. A. Robinson, W. H. Fleming, and T. A. Galbraith
Reply
Ann. Thorac. Surg., April 1, 1994; 57(4): 1053 - 1054.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.